get to the heart of every challenging case
From the first Anger Camera to dual detectors to CZT-based volumetric cardiac SPECT imaging technology and beyond, we have led the way in nuclear cardiac imaging for years. Today, the need for SPECT innovation is stronger than ever. In fact, cardiac procedures now account for over 50 percent of all nuclear medicine studies in the U.S.1 As the number of challenging cardiac patient cases grows, there’s a real need for cardiac-specific imaging solutions. Tough cardiac cases require a different approach to patient comfort, image quality and workflow. This is why we built MyoSPECTTM, a cardiac-dedicated SPECT designed and engineered from the inside out by the same manufacturer to accurately see the story in every heartbeat. The table is wider and the field-of-view is extended.2 MyoSPECT combines our exclusive stationary detector complete with our own CZT module design. MyoSPECT also delivers two attenuation compensation solutions, automated motion correction on XelerisTM and absolute myocardial blood flow readings with SPECT Flow. SPECT Flow combines dynamic acquisition on MyoSPECT with coronary flow reserve (CFR) and absolute myocardial blood flow, should you wish to use an external CT for attenuation correction. You can then generate all dynamic data processing and corresponding results with Xeleris applications. From form to function to the future, there has never been a more complete solution for cardiac imaging.

MyoSPECT Overview

  • Extended FOV processing for a 76% increase in FOV volume2
  • Smart Positioning workflow for automated scan position and FOV recommendations
  • Two different attenuation compensation solutions
  • True dynamic imaging with SPECT Flow

A perfect fit for today’s practice of cardiology

MyoSPECT was designed with the same focused attention to the heart that defines the entire practice of cardiology. With extended field-of-view processing and a more capable table, that’s also wider2, it comfortably accommodates all patients, large and small, with a complete picture of their heart. It’s the right balance of comfort and quality to fit your practice.
Design FWM

The view from here is complete

A little extra space is better for everyone, which is why we designed MyoSPECT to provide a 76 percent increase in field-of-view volume2. This gives you greater flexibility to position all of your patients, including obese patients. It’s a clear, more complete look at every patient’s heart.

Never miss a beat with CZT

A true negative diagnosis starts with CZT. The excellent energy and spatial resolution of our CZT detector technology is at the heart of every MyoSPECT image. CZT is also incredibly compact, which allowed us to pair it with a novel multi-pinhole collimator design, creating a tomographic imaging arc of the heart with motionless detectors, so every detector is focused on the heart simultaneously. Also, MyoSPECT ES3 comes with nine detectors, so you can choose the level of performance to meet the needs of your practice.
Never miss a beat with CZT
Image Quality
image quality

Smart heart imaging solutions

Because every patient is different, there is no one formula for image quality. Everything from positioning, to movement, to a patient’s BMI can affect your images. This can be especially challenging for high-throughput environments under pressure to maintain quality across a wide range of patient and exam types. MyoSPECT includes several new automated features that help make it easier to consistently achieve quality results. First, Smart Positioning Workflow is designed to bring your patients to the optimized position for scanning and guides you with prompts to help you get them there quickly. Then, MyoSPECT leverages device-less Alcyone Motion Detection and Correction on Xeleris to generate MotionFree images. With intelligent solutions like these, it’s hard not to acquire a quality image with MyoSPECT.
Image Quality

Straight to the heart of the matter

With two out of every 10 SPECT exams resulting in inconclusive stress perfusion4, attenuation correction and evaluation solutions are essential to capturing quality cardiac images. MyoSPECT gives you two options. You can correct attenuation by combining perfusion images with separate CT images on Xeleris. Or, since MyoSPECT uses a table for patient positioning, you can evaluate attenuation artifacts by imaging both prone and supine positions without adding additional radiation exposure. Both options have the added benefit of excellent CZT resolution. No matter which option you choose, you can be sure that nothing will get between you and a clear look at each patient’s heart.
myocardial blood flow

Analyze blood flow with absolute clarity

A dedicated cardiac imaging system requires dedicated technology to analyze blood flow. MyoSPECT includes SPECT Flow, which combines dynamic acquisition on MyoSPECT with CFR and absolute myocardial blood flow, should you wish to use an external CT for attenuation correction. All dynamic data processing and corresponding results are derived using Xeleris applications. The stationary design of MyoSPECT is one of the key features that makes SPECT Flow possible. In addition, high sensitivity enables short acquisition times, translating to reduced risk of motion artifacts associated with patient movement. With SPECT Flow, MyoSPECT provides valuable insight into each patient’s blood flow for true dynamic cardiac imaging and great diagnostic confidence.

Plan on a future of imaging every patient

An important part of our commitment to advancing cardiac SPECT technology is making it accessible to more people. It requires a thoughtful approach to how your system grows with your practice. With MyoSPECT ES3, you have a system built with flexibility. You can start with the essential cardiac imaging performance and add greater capacity and implement Quantitative Flow procedures when you need it. You can be confident that you are making the right investment to meet the needs of the community you serve today with a plan in place for the future.


Related products

1-IMV 2018 NM Market Outlook Report
2-As compared to Discovery™ NM 530c
3-Not CE marked. MyoSPECT ES may not be placed on the market nor put into service before CE marking.
4-Desmarais et al., JACC, 1993